NCT02187848: A trial that was reported late by Sanofi
This trial was previously reported as an Applicable Clinical Trial, but is no longer.
Full data
| Full entry on ClinicalTrials.gov | NCT02187848 |
|---|---|
| Title | A First-in-Human Study for the Evaluation of the Safety, Pharmacokinetics and Antitumor Activity of SAR408701 in Patients With Advanced Solid Tumors |
| Results Status | no-longer-act |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | July 23, 2014 |
| Completion date | Nov. 10, 2020 |
| Required reporting date | Nov. 10, 2021, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | March 9, 2023 |
| Days late | 483 |